Search Results | The Journal of Infectious Diseases

1-20 of 2754

Save search

Sort by

Sort Order Select

2 3 4 5

Journal Article

Comment on: A Call to Action: Urgently Strengthening the Future Physician-Scientist Workforce in Infectious Diseases

PDF

Aldo Barajas-Ochoa

The Journal of Infectious Diseases, jiae271, https://doi.org/10.1093/infdis/jiae271

Published: 22 May 2024

Journal Article

Reply to Barajas-Ochoa: The Imperative to Integrate International Medical Graduates into the Infectious Diseases Physician-Scientist Pathway: Expanding Opportunities and Overcoming Barriers

PDF

Talia H Swartz and others

The Journal of Infectious Diseases, jiae272, https://doi.org/10.1093/infdis/jiae272

Published: 22 May 2024

Journal Article

Reply to Antinori and Bausch-Jurken

PDF

Mackenzie d’Entremont-Harris and others

The Journal of Infectious Diseases, jiae128, https://doi.org/10.1093/infdis/jiae128

Published: 25 March 2024

Journal Article

Reply to Finsterer

PDF

Nelly Kanberg and others

The Journal of Infectious Diseases, Volume 229, Issue 3, 15 March 2024, Pages 920–921, https://doi.org/10.1093/infdis/jiad549

Published: 30 November 2023

Journal Article

Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment

PDF

Josef Finsterer

The Journal of Infectious Diseases, Volume 229, Issue 3, 15 March 2024, Pages 918–919, https://doi.org/10.1093/infdis/jiad548

Published: 30 November 2023

Journal Article

Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination

PDF

Lidya Handayani Tjan and others

The Journal of Infectious Diseases, Volume 226, Issue 8, 15 October 2022, Pages 1481–1483, https://doi.org/10.1093/infdis/jiac159

Published: 28 April 2022

Journal Article

Omicron BA.1, BA.2 and COVID-19 Booster Vaccination

PDF

Suvichada Assawakosri and others

The Journal of Infectious Diseases, Volume 226, Issue 8, 15 October 2022, Pages 1480–1481, https://doi.org/10.1093/infdis/jiac158

Published: 27 April 2022

Journal Article

Autoantibodies and COVID-19:  Rediscovering Nonspecific Polyclonal B-Cell Activation?

PDF

Nevio Cimolai

The Journal of Infectious Diseases, Volume 226, Issue 4, 15 August 2022, Pages 751–752, https://doi.org/10.1093/infdis/jiac105

Published: 22 March 2022

Journal Article

Reply to Cimolai: Post-COVID syndrome and autoimmunity

PDF

Yeny Acosta-Ampudia and Juan Manuel Anaya

The Journal of Infectious Diseases, Volume 226, Issue 4, 15 August 2022, Pages 753–754, https://doi.org/10.1093/infdis/jiac106

Published: 22 March 2022

Journal Article

Evolution of a 7-Mutant Strain of SARS-CoV-2 Within an Immunocompromised Person May Elucidate the Mechanism for the Generation of New Variants

PDF

Samarth Chandra

The Journal of Infectious Diseases, Volume 227, Issue 4, 15 February 2023, Page 602, https://doi.org/10.1093/infdis/jiac083

Published: 07 March 2022

Journal Article

Comment on “ Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads”

PDF

Chi Ching Kao and Yung Po Liaw

The Journal of Infectious Diseases, Volume 226, Issue 1, 1 July 2022, Page 188, https://doi.org/10.1093/infdis/jiac080

Published: 05 March 2022

Journal Article

Reply to Kao and Liaw

PDF

Valeria Ochoa and others

The Journal of Infectious Diseases, Volume 226, Issue 1, 1 July 2022, Page 189, https://doi.org/10.1093/infdis/jiac081

Published: 05 March 2022

Journal Article

Reply

PDF

Martina Bottanelli and others

The Journal of Infectious Diseases, Volume 225, Issue 11, 1 June 2022, Pages 2050–2051, https://doi.org/10.1093/infdis/jiac070

Published: 26 February 2022

Journal Article

Reply to Bottanelli et al

PDF

Joshua C Cyktor and others

The Journal of Infectious Diseases, Volume 225, Issue 11, 1 June 2022, Pages 2051–2052, https://doi.org/10.1093/infdis/jiac071

Published: 26 February 2022

Journal Article

Reply to Pati et al

PDF

Felipe Pérez-García and others

The Journal of Infectious Diseases, Volume 225, Issue 10, 15 May 2022, Pages 1866–1868, https://doi.org/10.1093/infdis/jiac027

Published: 29 January 2022

Journal Article

CCL5 rs2107538 Variant Is Associated With Protection Against SARS-CoV-2 Infection and Related Mortality: A Population-Based Study

PDF

Abhijit Pati and others

The Journal of Infectious Diseases, Volume 225, Issue 10, 15 May 2022, Pages 1865–1866, https://doi.org/10.1093/infdis/jiac026

Published: 29 January 2022

Supplementary data

Journal Article

Correspondence to Morbidity and Mortality Among Adults Experiencing Homelessness Hospitalized With Coronavirus Disease 2019

PDF

Yun-Hsin Chang and others

The Journal of Infectious Diseases, Volume 225, Issue 12, 15 June 2022, Page 2235, https://doi.org/10.1093/infdis/jiab625

Published: 24 December 2021

Journal Article

Unusual Interseasonal RSV Activity in the Southern and Northern Hemispheres

PDF

Andrew Anglemyer and others

The Journal of Infectious Diseases, Volume 225, Issue 9, 1 May 2022, Pages 1680–1682, https://doi.org/10.1093/infdis/jiab620

Published: 22 December 2021

Journal Article

Reply to Anglemyer et al

PDF

Florian Zeevat and others

The Journal of Infectious Diseases, Volume 225, Issue 9, 1 May 2022, Page 1682, https://doi.org/10.1093/infdis/jiab621

Published: 22 December 2021

Journal Article

Reply To Chang and Liaw

PDF

Gaston Ofman and Mark L Lang

The Journal of Infectious Diseases, Volume 225, Issue 8, 15 April 2022, Pages 1494–1495, https://doi.org/10.1093/infdis/jiab618

Published: 20 December 2021

2 3 4 5

Modify your search

Availability

NARROW

Format

Type

Section

Category

Publication date

Comment on: A Call to Action: Urgently Strengthening the Future Physician-Scientist Workforce in Infectious Diseases

Reply to Barajas-Ochoa: The Imperative to Integrate International Medical Graduates into the Infectious Diseases Physician-Scientist Pathway: Expanding Opportunities and Overcoming Barriers

Reply to Antinori and Bausch-Jurken

Reply to Finsterer

Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment

Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination

Omicron BA.1, BA.2 and COVID-19 Booster Vaccination

Autoantibodies and COVID-19:  Rediscovering Nonspecific Polyclonal B-Cell Activation?

Reply to Cimolai: Post-COVID syndrome and autoimmunity

Evolution of a 7-Mutant Strain of SARS-CoV-2 Within an Immunocompromised Person May Elucidate the Mechanism for the Generation of New Variants

Comment on “ Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads”

Reply to Kao and Liaw

Reply

Reply to Bottanelli et al

Reply to Pati et al

CCL5 rs2107538 Variant Is Associated With Protection Against SARS-CoV-2 Infection and Related Mortality: A Population-Based Study

Correspondence to Morbidity and Mortality Among Adults Experiencing Homelessness Hospitalized With Coronavirus Disease 2019

Unusual Interseasonal RSV Activity in the Southern and Northern Hemispheres

Reply to Anglemyer et al

Reply To Chang and Liaw

Email alerts

Modify your search

Publication date

Email alerts

This Feature Is Available To Subscribers Only